Sorin reported flat results for Q1, but sees expected FDA approval of its Perceval sutureless aortic valve as helping to accelerate growth in the 2015 second half. Results from three new studies of the implant underscore its potential market potential.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1JQy6Pn
Cap comentari:
Publica un comentari a l'entrada